Our #Paediatric Task Force is embarking on an update to the ‘Paediatric Classification of Pulmonary Vascular Disease’. It was first introduced & agreed upon at the #PVRI2011 Panama meeting & published in #PulmonaryCirculation, with the first functional classification of PH for children and infants.

Today on 🫁 #WorldLungDay 🫁 & beyond, we’re reminded that healthy lungs are vital for every breath we take. #PulmonaryHypertension is a serious condition affecting people worldwide. With your help, we can drive research forward, improve treatments, & bring hope to patients across the world. 👇

Meet the Living Legend: Lewis Rubin, University of California San Diego 9 October 2025, 16:00 BST 👉 Register: pvrinstitute.org/learning-hub... Part of the PVRI Digital Webinar Series, 'Living Legends in Pulmonary Hypertension: History & Personal Perspectives' sessions.

Missed our #CommunityCall on Friday with guest authors Grazyna Kwapiszewska, Slaven Crnkovic & Athiththan Yogeswaran? Here is a sneak peek... Watch the full recording: pvrinstitute.org/learning-hub...

Today at 15:00 BST, we look forward to welcoming guest speakers Grazyna Kwapiszewska, Slaven Crnkovic and Athiththan Yogeswaran. Hope to see you there! Register here: pvrinstitute.org/learning-hub...

🗓️ Happening tomorrow - 19 September, 15H00 BST Join us for our informal #PulmonaryHypertension #CommunityCall as we welcome guest authors Grazyna Kwapiszewska, Slaven Crnkovic and Athiththan Yogeswaran. Register: pvrinstitute.org/learning-hub...

🌎 Did you know…? ...74% (1,513 out of 2,045 respondents) of adult patients with #pulmonaryhypertension have had their employment or education negatively impacted to some degree! Read the full #PHGPS paper to explore more findings 👉 doi.org/10.1183/2312...

Our Women's Health & #PulmonaryVascularDisease webinar (brought to you by the #PVRI Women's Health Task Force) includes research presentations on sex differences and sex hormone treatments in pulmonary arterial hypertension (#PAH). Watch the full webinar here: pvrinstitute.org/learning-hub...

#PVRI2026 includes sessions on promising novel targets and pathways in #PAH, along with real-world data of #Sotatercept. 🗓️ Get your #abstract in before the closing date of 01 October! 🎟️ Register soon to secure a place in one of the PVRI reserved hotels! pvrinstitute.org/pvri2026

Miss our #PVRIdigital Webinar: #Sotatercept: New Concepts & Clinical Use? PVRI members can watch it on demand: pvrinstitute.org/learning-and... - this webinar is part of the 'Cutting Edge Innovation in Clinical & Experimental PH' sessions.

Join us on 19 September 2025, 15H00 BST for our next PVRI Community Call as we welcome guest authors, Grazyna Kwapiszewska, Slaven Crnkovic and Athiththan Yogeswaran. Our Calls are informal, free, and open to everyone. Register pvrinstitute.org/learning-hub...

Happening today! With nearly 500 attendees registered, we can't wait to see you there!

Happening tomorrow! Join live at 16:00 BST, all welcome 👉 pvrinstitute.org/learning-hub...

Women’s Health and Pulmonary Vascular Disease free webinar! Join us TODAY 15:00 BST to hear from experts, and help shape the Task Force’s direction. Everyone is welcome, register: us02web.zoom.us/webinar/regi... #WomensHealth #PulmonaryHypertension #PulmonaryVascularDisease

📢 NEW PVRI Digital Webinar 'Sotatercept: New Concepts and Clinical Use' happening next week! Speakers include: Luke Howard, Franz Rischard, David Montani, Rahul Argula Register for free 👉 pvrinstitute.org/learning-hub...

New publication: How Is Pulmonary Hypertension Characterised and Treated in Children With Trisomy 21? Observations From the TOPP Registry (Tracking Outcomes and Practice in Pediatric Pulmonary Hypertension) by Tilman Humpl Et al. Read the full research article onlinelibrary.wiley.com/doi/10.1002/...

The wait is over… the preliminary programme for #PVRI2026 Dublin is here! From sotatercept & translational science to AI, biomarkers, & global PH challenges, PVRI 2026 will showcase innovation shaping the next 20 years of #PH. Explore the programme 👉 pvrinstitute.org/learning-hub...

🎥 Did you miss our live session on the #PulmonaryHypertension Global #Patient Survey? ▶️ Watch on-demand pvrinstitute.org/learning-hub... Hall Skaara & Wendy Gin-Sing unpacked the EU adult findings, covering time to diagnosis, quality of life, access to care, & 10 Calls to Action #PHGPS

New publication: Pulmonary Vascular Compromise Is Associated With Survival in Pediatric Pulmonary Hypertension: A New Computational Model by Maria Niccum Et al. Read the full research article➡️ doi.org/10.1002/pul2...

Happening tomorrow! Join live at 13:00 BST 👉 register for free us02web.zoom.us/webinar/regi...

New publication: Renal Outcomes After Lung or Combined Heart-Lung Transplantation in Pulmonary Hypertension by Laura Hardy Et al. Read the full research article➡️ onlinelibrary.wiley.com/doi/10.1002/...

New publication: Analysis of Clinical Characteristics of 54 Dead Pregnant Patients With Pulmonary Hypertension by Lishi Chen Et al. Read the full research article➡️ onlinelibrary.wiley.com/doi/10.1002/...

⏰ Happening THIS Friday! Don’t miss our free webinar on the European findings from the PH Global Patient Survey (PHGPS). Hear from Hall Skaara & Frances Varian on diagnosis, quality of life, access to care + the 10 Calls to Action 👉 us02web.zoom.us/webinar/regi...

⏰ Happening 3PM BST tomorrow! Don’t miss this free session in the iPVD Virtual Symposium Series. Register now us02web.zoom.us/webinar/regi... #PVD #PulmonaryHypertension #Infection #Inflammation #Webinar

New publication: Global, Regional, and National Burden of Pulmonary Arterial Hypertension Among Women of Childbearing Age, 1990–2021: A Systematic Analysis for the Global Burden of Disease Study 2021 by Junjun Liu Et al. Read the full research article➡️ doi.org/10.1002/pul2...

Happening next week! Register for free & join the discussion 🎦 us02web.zoom.us/webinar/regi...

Heading to #PVRI2026 Dublin? Don’t miss our satellite meetings (28 Jan & 1 Feb)—free & open to all! ✔ Imaging ✔ Paediatric ✔ Latin America ✔ iPVD ✔ IDDI ✔ High Altitude ✔ PAH-ICON Be part of the global PVD conversation🌍 👉 Register now: pvrinstitute.org/learning-hub...

🌍 #BreathBeyondBorders Challenge 🌍 This #PHAwarenessMonth, PVRI members & friends around the world are uniting to push their limits — running, walking, cycling, swimming, even playing the piano — all in support of PH research & innovation. Want to be part of it? 👉 pvrinstitute.org/breathbeyond...

New publication: Relationship Between Phenotypical and Echocardiographic Findings With Pulmonary Hypertension in COPD Patients by Sayyed Gholamreza Mortazavi Moghaddam Et al. Read the full research article doi.org/10.1002/pul2...

📢 From Patient Voices to Action: Understanding the PH Global Survey - A Webinar for Patients and Carers on #PHGPS European Findings 📅 Friday, 29 August | 🕚 11:00 BST Register for free us02web.zoom.us/webinar/regi... #PH #PatientWebinar #PatientCare

New publication: Predicting Response to Switching From Phosphodiesterase Type 5 Inhibitor to Riociguat in Patients With Pulmonary Arterial Hypertension: Biomarker and Responder Analysis of the RESPITE and REPLACE Studies by James R. Klinger Et al onlinelibrary.wiley.com/doi/10.1002/...

🌍 Did you know? ...in 2023/4 over 3000 patients or their loved ones responded to the Pulmonary Hypertension Global Patient Survey, providing a unique insight to their lived experience with the disease. Read the full #PHGPS paper to explore the key findings 👉 doi.org/10.1183/2312...

Next in our #HighAltitude Webinar Series: A Matter of Degrees. The remarkable life of Mabel Purefoy FitzGerald, a pioneer in #hypoxia acclimatization🗻 📅 2 September 2025 | 13:00 BST 🎙️ Martha Tissot van Patot, Aastha Mishra & Ulrich Silvia Free & open to all us02web.zoom.us/webinar/regi...

The @pvrinstitute.bsky.social has released 10 global priorities for improving #patientcare after analyzing results from its Pulmonary Hypertension Global Patient Survey. Learn more: buff.ly/ngsNCUa

🌍 Upcoming webinar – free & open to all! Join us for the next session in the iPVD Virtual Symposium Series, where Prashant Bobhate will be discussing 'Pulmonary Hypertension in the Shadow of Infections: Challenges in Indian Practice'. Register for free us02web.zoom.us/webinar/regi...

New publication: Effect of Regulating FUNDC1 Mitophagy-Mediated cGAS/STING Pathway in Oleic Acid-Induced Acute Lung Injury Model by Liangyu Mi Et al. Read the full research article 👉 doi.org/10.1002/pul2...

What is #BreathBeyondBorders? A global fundraising challenge to raise awareness about the importance of research and innovation in #pulmonaryhypertension, and show the strength of the global #PH community 🌍 Sign up & find out more pvrinstitute.org/breathbeyondborders #PHResearch #PVRI2026

New publication: Characterization of the Population With Intermediate-Risk Status in Pulmonary Arterial Hypertension: Patients in a Latin American Country: The CAPRI Registry by R. Conde-Camacho Et al. Read the full research article 👉 onlinelibrary.wiley.com/doi/10.1002/...

Missed our Paediatric Bridge to Transplant webinar? 🎥 The recording’s now available on demand! Hear expert insights on mechanical support strategies from infancy to adolescence pvrinstitute.org/learning-hub... #PaediatricTransplant #PulmonaryHypertension

📢 Happening Tomorrow: Paediatric Bridge to Transplant 📅 29 July 2025, 16:00 BST Our Lung Transplantation in #PulmonaryHypertension Workstream will be presenting a webinar on expert strategies for bridging paediatric patients to lung transplant. Register for free 👉 us02web.zoom.us/webinar/regi...

🚨 Women’s Health Task Force is back — join us for a dedicated webinar on 9 September (3PM BST) to explore women’s health and pulmonary vascular disease, with expert speakers Steve Kawut, Jackie DesJardin, Jessica Badlam, & Meghan Cirulis. Register for free👉 pvrinstitute.org/learning-hub...

📽️Catch up on Martin Wilkins’ presentation from #DDDS2025, where he explored the limitations of relying on single reading averages from traditional clinical trials and made the case for n-of-1 studies in PAH pvrinstitute.org/learning-hub... #PAH #ClinicalTrials #DrugDevelopment #DDDS2025

📢Call for Abstracts We’re inviting abstracts across four exciting themes: 1. Basic & Translational Science 2. Clinical Science 3. International & Global Health 4. Mind the Gap: Cases that Highlight Gaps in Evidence Submit your research for #PVRI2026 by 1 Oct 2025 pvrinstitute.org/learning-hub...

🌍 Ready to take on a fitness challenge with global impact for pulmonary hypertension? Join #BreathBeyondBorders this November for #PHAwarenessMonth Find out more pvrinstitute.org/breathbeyondborders

New publication: Risk Assessment Models and Event-Free Survival in Pulmonary Arterial Hypertension by Clara Hjalmarsson Et al. Read the full research article 👉 doi.org/10.1002/pul2...

🎉 Our #PVRIDigital Webinar Series is back this September! Join us for inspiring keynote talks from global PH experts. A huge thank you to our organising committee for an incredible programme ahead! Find out more pvrinstitute.org/PVRIDigital

📢 New publication from our Paediatric Clinical Trial Design & Endpoints Workstream: Enhancing Drug Development for Paediatric Pulmonary Hypertension—An Integrative Perspective by Steven Abman Et al. Read the full review article 👉 onlinelibrary.wiley.com/doi/10.1002/...

📢 NEW Webinar: Paediatric Bridge to Transplant 📅 29 July 2025, 16:00 BST Our Lung Transplantation in #PulmonaryHypertension Workstream will be presenting a webinar on expert strategies for bridging paediatric patients to lung transplant. Register for free 👉 pvrinstitute.org/learning-hub...

📢 Good news! 📢 Our #PHGPS, the largest global survey exploring the perspectives of #PulmonaryHypertension patients, has identified 10 key global priorities for improving #PulmonaryHypertension care in adult patients. Read more 👉 doi.org/10.1002/pul2...

How to define or prove disease modification - catch up on ‪@mark-toshner.bsky.social‬ thought-provoking talk from #DDDS2025 🎥 pvrinstitute.org/learning-hub... #PAH #BMP #Imatinib #Sotatercept #DiseaseModification